Clinical trial
Standard Versus Continuous Capecitabine in Advanced Breast Cancer
NCT00418028 · Hospital San Carlos, Madrid, Other · Completed
Key facts
| NCT number | NCT00418028 |
|---|---|
| Title | Standard Versus Continuous Capecitabine in Advanced Breast Cancer |
| Official title | Randomized Phase II Trial of Continuous Versus Standard Capecitabine in Advanced Breast Cancer. |
| Lead sponsor | Hospital San Carlos, Madrid, Other |
| Collaborators | Complexo Hospitalario Universitario de A Coruña |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Metastatic Breast Cancer |
| Intervention type | Drug |
| Interventions | Capecitabine |
| Enrollment | 195 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2011 |
| Completion | Jan 1, 2015 |
| First posted | Jan 4, 2007 |
| Last update posted | Feb 22, 2019 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: